Feb 28 (Reuters) - Praxis Precision Medicines PRAX.O said on Friday an independent committee had recommended its tremor drug trial be stopped for futility, as it was unlikely to meet its main goal.
(Reporting by Sriparna Roy in Bengaluru; Editing by Shreya Biswas)
((Sriparna.Roy@thomsonreuters.com;))